# US 2026/0097165 A1 · System for drug delivery with fixed dose size

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0097165 A1
- Document ID: US20260097165A1
- Status: Published application
- Kind: A1
- Application number: 19/416,189
- Filed: 2025-12-11
- Published: 2026-04-09
- Earliest claimed: 2024-01-02
- Assignees: Manta MedTech LLC
- Applicants: Manta MedTech LLC
- Inventors: Raju S. DAVE; Xing SU; Himanshu VERMA; Ashish Shah; Kenta Alten
- Web page: https://patentgrep.com/patent/US20260097165A1

## CPC

- A61M 5/14248: {of the skin patch type}
- A61M 5/1409: {in series, e.g. reconstitution systems with a first substance passing through a container holding a second substance}
- A61M 5/14276: {specially adapted for implantation}
- A61M 5/14526: {the piston being actuated by fluid pressure}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61M 35/10: {Wearable devices, e.g. garments, glasses or masks}
- A61M 5/16831: {Monitoring, detecting, signalling or eliminating infusion flow anomalies (low-level float-valves causing cut-off A61M5/40; indicating or recording presence, absence or direction of flow in general G01P13/0066)}
- A61M 5/16877: {Passive flow controllers; Devices for setting a flow rate (clamp-type valves A61M39/28)}
- A61M 2005/14252: {with needle insertion means}
- A61M 2037/0023: {Drug applicators using microneedles}
- A61M 2202/0007: introduced into the body
- A61M 2205/0216: Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
- A61M 2205/04: implanted
- A61M 2205/3327: Measuring
- A61M 2205/3334: Measuring or controlling the flow rate
- A61M 2205/3507: with implanted devices, e.g. external control
- A61M 2209/088: on the body
- A61M 2210/04: Skin
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Embodiments relate to systems comprising Active Wearable Medical Device (AWMD) with an osmotic chamber containing or configured to receive an osmotic agent, a permeability module for fluid ingress, and a drug chamber holding a drug. A compressible piston, positioned between the chambers, moves longitudinally as a whole during operation. The compressible piston advances toward the drug chamber when a valve opens, enabling drug release through one or more outlets, and retracts when the valve closes, driven by osmotic pressure. A valve module regulates this flow. The system also comprises a fluid chamber containing fluid and a semipermeable membrane coupling it to the AWMD. A channel connected to the drug outlets delivers the drug externally.

## Claims

### Claim 1

A system comprising:
(1) an active wearable medical device (AWMD) comprising:
an osmotic chamber comprising an osmotic agent or being provided to receive the osmotic agent;
a permeability module to allow ingress of a fluid into the osmotic chamber;
a drug chamber comprising a drug;
a compressible piston located between the osmotic chamber and the drug chamber and comprising a cross sectional area, a drug chamber-facing surface and an osmotic chamber-facing surface; and
a valve module comprising a valve to allow flow of the drug from the drug chamber to outside the AWMD through one or more drug outlets present in the AWMD;
wherein the compressible piston is configured to deform such that its drug chamber-facing surface moves toward the drug chamber when the valve is opened, and the osmotic chamber-facing surface follows when the valve is closed, resulting in a net longitudinal displacement of the piston as a whole;
(2) a fluid chamber that contains the fluid; and
(3) a channel fluidically coupled to one or more drug outlets, the channel being configured to discharge and deliver the drug;
wherein the AWMD is not implanted in a body of a mammal, and wherein the AWMD further comprises a semipermeable membrane fluidically coupling the fluid chamber to the osmotic chamber.

### Claim 2 (depends on 1)

The system of claim 1, wherein the fluid chamber is an expandable elastomeric bladder that expands and gradually releases the fluid across the semipermeable membrane to generate the osmotic pressure when a pressure is applied to the expandable elastomeric bladder.

### Claim 3 (depends on 1)

The system of claim 1, wherein the fluid chamber is a rigid reservoir that enables diffusion of the fluid across the semipermeable membrane to dissolve an osmotic agent in the osmotic chamber and generate an osmotic gradient to drive the piston.

### Claim 4 (depends on 1)

The system of claim 1, wherein the fluid chamber is a Hydrogel reservoir.

### Claim 5 (depends on 4)

The system of claim 4, wherein the Hydrogel reservoir comprises a hydrogel that releases the fluid over time to enable the passive ingress flow of the fluid to the osmotic chamber from the Hydrogel reservoir.

### Claim 6 (depends on 1)

The system of claim 1, wherein the fluid chamber is a microfluidic reservoir.

### Claim 7 (depends on 6)

The system of claim 6, wherein the microfluidic reservoir is integrated with a flow restrictor interfaced with the semipermeable membrane to deliver the fluid to the osmotic chamber at a controlled rate.

### Claim 8 (depends on 1)

The system of claim 1, wherein the fluid chamber is an active operated chamber.

### Claim 9 (depends on 1)

The system of claim 1, wherein the fluid chamber is a passive operated chamber.

### Claim 10 (depends on 1)

The system of claim 1, wherein the channel comprises a catheter configured to deliver the drug to a specific anatomical site.

### Claim 11 (depends on 10)

The system of claim 10, wherein the catheter is configured for targeted administration of the drug.

### Claim 12 (depends on 1)

The system of claim 1, wherein the system comprises an attachment component having perforations adapted to secure the system to skin and to ensure stable contact with the skin during the discharge of the drug.

### Claim 13 (depends on 1)

The system of claim 1, wherein the channel comprises a biocompatible material.

### Claim 14 (depends on 1)

The system of claim 1, wherein the drug chamber comprises a plurality of drug chambers.

### Claim 15 (depends on 14)

The system of claim 14, wherein the system is configured to switch between the plurality of drug chambers for sequential discharge of the drug or combination of discharge of the drug.

### Claim 16 (depends on 1)

The system of claim 1, wherein the channel comprises a dissolvable material that naturally dissolves in the body over a period of time.

### Claim 17 (depends on 10)

The system of claim 10, wherein the system comprises a real-time imaging and navigation guidance device.

### Claim 18 (depends on 17)

The system of claim 17, wherein the real-time imaging and navigation guidance device is configured to aid placement of the catheter and monitor dispersion of the drug in real-time.

### Claim 19 (depends on 12)

The system of claim 12, wherein the attachment component comprises an adhesive layer.

### Claim 20 (depends on 12)

The system of claim 12, wherein the attachment component comprises one of a mechanical fastener, a wearable strap, a wearable band, and a skin micro-anchor.
